Blog
12-16-2024Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not reduce the time to lesion resolution...
NIAID Newsroom
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain - Blog
Kidney Transplantation Between Donors and Recipients with HIV Is Safe 10-17-2024Cross-posted from: NIAID Newsroom Kidney transplantation from deceased donors with HIV (HIV D+) to recipients... - Blog
Exploratory Analysis Associates HIV Drug Abacavir with Elevated Cardiovascular Disease Risk in Large Global Trial 07-26-2024Cross-posted from: NIAID Newsroom Transmission electron micrograph of HIV-1 virus particles (teal) budding and... - Blog
Long-Acting Injectable Cabotegravir for HIV Prevention Is Safe in Pregnancy 07-25-2024Cross-posted from: NIAID Newsroom Transmission electron micrograph of HIV-1 virus particles (green) replicatin... - Blog
An Isolated Viral Load Test May Generate False Positive Results for People Using Long-Acting PrEP 07-23-2024Colorized transmission electron micrograph of multiple HIV-1 virus particles (green) budding from a cell projec... - Blog
U.S. Clinical Trials Begin for Twice-Yearly HIV Prevention Injection 06-07-2024Cross-posted from NIAID Newsroom Colorized transmission electron micrograph of numerous HIV-1 virus particles... - Blog
Sexually Transmitted Infections—A Closer Look at NIAID Research 04-17-2024Sexually transmitted infections (STIs) are caused by bacteria, viruses, or parasites. STIs have a devastating... - Blog
Statement: Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed 02-22-2024Cross-posted from: NIAID Newsroom Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine... - Blog
Working Together to End HIV in Black Communities 02-07-2024Health inequities and disparities disproportionately affect Black people and other historically marginalized gro... - Blog
Biomedical STI Prevention Evidence Is Inadequate for Cisgender Women 01-10-2024Note: As we continue to pursue the goals of both the STI National Strategic Plan and National HIV/AIDS Strateg... - Blog
NIH Research Identifies Opportunities to Improve Future HIV Vaccine Candidates 12-20-2023Cross-posted from: NIAID Newsroom An effective HIV vaccine may need to prompt strong responses from immune... - Blog
NIH Statement on Preliminary Efficacy Results of First-in-Class Gonorrhea Antibiotic Developed Through Public-Private Partnership 11-14-2023Scanning electron micrograph of Neisseria gonorrhoeae bacteria, which causes gonorrhea. Captured by the Research... - Blog
The STOMP Trial Evaluates an Antiviral for Mpox 10-10-2023Cross-posted from:NIAID Newsroom Following a peak in the summer of 2022, new infections in the mpox clade IIb outbreak have decreased, due in part to the... - Blog
Clinical Trial of HIV Vaccine Begins in United States and South Africa 09-26-2023Cross-posted from: NIAID newsroom Transmission electron micrograph of HIV-1 virus particles from infected H9 c... - Blog
Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds 04-14-2023Cross-posted from NIAID Newsroom A National Institutes of Health (NIH) clinical trial was stopped early because... - Blog
Experimental HIV Vaccine Regimen Safe but Ineffective, NIH Study Finds 01-19-2023Cross-posted from NIAID Newsroom An investigational HIV vaccine regimen tested among men who have sex with men... - Blog
Early HIV Diagnosis and Treatment Important for Better Long-term Health Outcomes 11-02-2022Cross-posted from NIAID Newsroom Antiretroviral drugs to treat HIV infection Credit: NIAID Starting antiretro... - Blog
Three-dose Hepatitis B Vaccine Regimen Protects People with HIV 10-21-2022Cross-posted from NIH s NIAID Newsroom Finding is part of an ongoing clinical trial. A three-dose course of... - Blog
Clinical Trial Evaluating Monkeypox Vaccine Begins 09-09-2022Cross-posted from NIAID Newsroom NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply.... - Blog
Combination Anti-HIV Antibody Infusions Suppress Virus for Sustained Period 06-02-2022